Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach-Reference-Cited by-同舟云学术

Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach

Published:2015-12-12 Issue:4 Volume:142 Page:849-858
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Lee Joo Yong,Kang Ho Won,Rha Koon Ho,Cho Nam Hoon,Choi Young Deuk,Hong Sung Joon,Cho Kang Su

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-015-2093-0.pdf

Reference54 articles.

1. Abdollah F, Suardi N, Cozzarini C et al (2013) Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 63(6):998–1008

2. Adolfsson J, Steineck G, Hedlund PO (1999) Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup. J Urol 161(2):505–508

3. Bastide C, Rossi D, Lechevallier E et al (2012) Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy? BJU Int 109(4):525–530 discussion 531–522

4. Berry DA (2006) Bayesian clinical trials. Nat Rev Drug Discov 5(1):27–36

5. Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK (2011) Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer 117(13):2883–2891

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study;Clinical Interventions in Aging;2024-06

2. Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study;BMC Cancer;2023-09-28

3. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma;World Journal of Gastrointestinal Oncology;2023-06-15

4. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy;Journal of Clinical Medicine;2022-11-14

5. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response;World Journal of Urology;2022-10-26